Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP625029.RAazls0bk3fsFcltwwLz_e5b-h0kPbBApgb4dfy9aeXqg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP625029.RAazls0bk3fsFcltwwLz_e5b-h0kPbBApgb4dfy9aeXqg130_assertion type Assertion NP625029.RAazls0bk3fsFcltwwLz_e5b-h0kPbBApgb4dfy9aeXqg130_head.
- NP625029.RAazls0bk3fsFcltwwLz_e5b-h0kPbBApgb4dfy9aeXqg130_assertion description "[Activation of the ERBB PI3K/Akt pathway was positively correlated with a higher stage (p=0.001), higher grade (p=0.001), histological type II disease (p=0.0003) and metastases (p=0.02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625029.RAazls0bk3fsFcltwwLz_e5b-h0kPbBApgb4dfy9aeXqg130_provenance.
- NP625029.RAazls0bk3fsFcltwwLz_e5b-h0kPbBApgb4dfy9aeXqg130_assertion evidence source_evidence_literature NP625029.RAazls0bk3fsFcltwwLz_e5b-h0kPbBApgb4dfy9aeXqg130_provenance.
- NP625029.RAazls0bk3fsFcltwwLz_e5b-h0kPbBApgb4dfy9aeXqg130_assertion SIO_000772 24337234 NP625029.RAazls0bk3fsFcltwwLz_e5b-h0kPbBApgb4dfy9aeXqg130_provenance.
- NP625029.RAazls0bk3fsFcltwwLz_e5b-h0kPbBApgb4dfy9aeXqg130_assertion wasDerivedFrom befree-20150227 NP625029.RAazls0bk3fsFcltwwLz_e5b-h0kPbBApgb4dfy9aeXqg130_provenance.
- NP625029.RAazls0bk3fsFcltwwLz_e5b-h0kPbBApgb4dfy9aeXqg130_assertion wasGeneratedBy ECO_0000203 NP625029.RAazls0bk3fsFcltwwLz_e5b-h0kPbBApgb4dfy9aeXqg130_provenance.